U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07946198) titled 'Effect of Increased Dialysis Versus Hemofiltration' on Nov. 12.
Brief Summary: Regional citrate anticoagulation is commonly used during continuous kidney replacement therapy (CKRT) in critically ill patients. Citrate prevents clotting in the extracorporeal circuit by reducing ionized calcium concentrations. However, adequate anticoagulation is not always achieved, and the influence of dialysis and hemofiltration on citrate removal and post-filter ionized calcium remains incompletely understood.
This prospective, single-center, interventional study compares two strategies for increasing extracorporeal clearance in critically ill pat...